Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fulgent Pharma Llc.

Clinical trials sponsored by Fulgent Pharma Llc., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat head and neck cancers

Disease control Ongoing

This study is testing a new drug, FID-007, given alongside an existing cancer drug called cetuximab. It aims to see if this combination can help control advanced head and neck cancer that has come back or spread after prior treatment. Researchers will compare two different dosing…

Phase: PHASE2 • Sponsor: Fulgent Pharma LLC. • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC